Enhancing T‐cell responses to GCB‐like lymphomas with immune‐checkpoint‐blockade‐based therapies.Published in:Hematological Oncology, 2023, v. 41, p. 280, doi. 10.1002/hon.3164_192By:Serganova, I.;Bucktrout, R.;Isshiki, Y.;Sarapulov, A.;Santella, A.;Rodriguez, M.;Chakraborty, S.;Brunschvig, S.;Qualls, D.;Vardhana, S.;Lesokhin, A.;Melnick, A.;Beguelin, W.;Zappasodi, R.Publication type:Article